Heart Health
Bempedoic Acid Cuts Venous Clot Risk by 42% in Statin-Intolerant Patients
A post hoc analysis of the CLEAR Outcomes trial finds bempedoic acid significantly reduces DVT and pulmonary embolism risk.
Research Paper
May 29, 2026 0
Results for "Bempedoic Acid" in Heart Disease
20 articles
Heart Health
Bempedoic Acid Plus Ezetimibe Combo Targets LDL in Diabetic Patients
A Phase 2 trial tests whether a fixed-dose combination pill can safely lower LDL cholesterol in people with type 2 diabetes.
Clinical Trial
Jun 17, 2026 0
Heart Health
Heart Drug Memantine Cuts Dangerous Irregular Heartbeats by Nearly Half
Clinical trial shows memantine reduces premature atrial contractions by 47% and prevents atrial fibrillation in heart patients.
Research Paper
Mar 28, 2026 0
Heart Health
Baxdrostat Phase 2a Study Correction Published in New England Journal
NEJM publishes erratum for Phase 2a study of baxdrostat in primary aldosteronism treatment
Research Paper
Apr 9, 2026 0
Heart Health
Obicetrapib Shows Promise for Heart Disease and Alzheimer's Prevention
Peter Attia explores a new CETP inhibitor that may reduce cardiovascular risk and protect against Alzheimer's disease in APOE4 carriers.
Podcast
Apr 2, 2026 0
Heart Health
New Drug Baxdrostat Shows Promise for Treatment-Resistant High Blood Pressure
Novel medication lowers stubborn blood pressure by 5% and reduces kidney damage markers by 55% in patients with chronic kidney disease.
Press Release
Mar 28, 2026 0
Heart Health
Why Fenofibrate Outperforms Other Fibrates for Cardiovascular Risk
Not all fibrates work the same way — fenofibrate uniquely reduces apoB, cutting residual cardiovascular risk beyond statins alone.
Research Paper
Jun 6, 2026 0
Heart Health
Methylene Blue Emerges as a Promising Rescue Drug for Refractory Shock in the ICU
A 2025 review examines how methylene blue's nitric oxide inhibition can restore vascular tone in septic and vasoplegic shock patients.
Research Paper
May 14, 2026 0
Heart Health
Chinese PCSK9 Inhibitor Trial Tests IBI306 for High-Risk Cholesterol Patients
Phase 3 trial of IBI306, a PCSK9 inhibitor, tests LDL-C reduction in Chinese adults with high cardiovascular risk on statin therapy.
Clinical Trial
Jun 7, 2026 0
Heart Health
Amiloride Shows Promise for Coronary Heart Disease Through Red Blood Cell Enhancement
Small trial explores how amiloride improves oxygen delivery to heart muscle by enhancing potassium transport in red blood cells.
Clinical Trial
Mar 28, 2026 4
Heart Health
Anacetrapib Added to Statins Tested for Cholesterol Control in Phase 3 Trial
Merck's CETP inhibitor anacetrapib was evaluated alongside statin therapy to assess LDL-C lowering and HDL-C raising in hypercholesterolemia patients.
Clinical Trial
Jun 15, 2026 0
Heart Health
Phase 3 Trial Tests Obicetrapib for Hard-to-Treat High Cholesterol
A completed Phase 3 trial evaluates obicetrapib added to maximum lipid-lowering therapy in patients with familial hypercholesterolemia and ASCVD.
Clinical Trial
Jun 12, 2026 0
Heart Health
Merck's Niacin-Laropiprant Cholesterol Trial Terminated Before Completion
A phase 3 trial adding ERN/LRPT to statin therapy for dyslipidemia was terminated early, raising questions about the drug's clinical future.
Clinical Trial
May 26, 2026 0
Heart Health
Obicetrapib Cuts Coronary Events 32% in High-Risk Heart Patients
A pooled analysis of 2,884 patients finds obicetrapib significantly reduces coronary events after 6 months, with striking lipid improvements.
Research Paper
Jun 4, 2026 0
Heart Health
Common Heartburn Drugs May Reduce Blood Thinner Effectiveness in Heart Patients
New research examines whether proton pump inhibitors interfere with clopidogrel's protective effects against heart attacks.
Research Paper
Mar 28, 2026 1
Heart Health
Elamipretide Wins First FDA Approval for Barth Syndrome Via Mitochondrial Repair
The first disease-specific treatment for Barth syndrome gains FDA accelerated approval, targeting mitochondrial dysfunction to restore muscle strength.
Research Paper
May 20, 2026 0
Heart Health
Heart Drug Finerenone Shows Promise for Preventing Dangerous Irregular Heartbeat
New research reveals finerenone may reduce new-onset atrial fibrillation in heart failure patients with preserved ejection fraction.
Research Paper
Mar 28, 2026 1
Heart Health
PCSK9 Inhibitors Cut Heart Attack Risk 37% in Peripheral Artery Disease Patients
New meta-analysis shows PCSK9 inhibitors significantly reduce cardiovascular events and major amputations in PAD patients beyond standard statin therapy.
Research Paper
Mar 28, 2026 0
Heart Health
New PCSK9 Inhibitor Lerodalcibep Heads to Head Against Evolocumab in Rare Cholesterol Disorder
A Phase 3 trial pits monthly lerodalcibep against evolocumab in homozygous familial hypercholesterolemia patients over 24 weeks.
Clinical Trial
Jun 16, 2026 0
Heart Health
Natural Compound From Chinese Root Blocks Inflammation That Drives Heart Disease
Isolinderalactone from Lindera aggregata root reduces atherosclerotic plaques by targeting key inflammatory pathways in immune cells.
Research Paper
Mar 29, 2026 1
Page 1 of 2Next